BioLargo Inc - SIC # 2899 - CHEMICALS AND CHEMICAL PREPARATIONS, NOT ELSEWHERE CLASSIFIED

Ticker Exchange SIC # Website Latest Ticker
BLGO Over the counter 2899 http://biolargo.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for BioLargo Inc

BioLargo to Appear on ClearThink IR's Virtual Live Event on Wednesday, January 25, 2023 at 12 Noon ET - Jan 24th, 2023 1:30 pm
BioLargo Grew 2022 Revenue by More Than 125% Over the Prior Year - Jan 9th, 2023 1:30 pm
BioLargo's Partner Ikigai Begins Sales of Pooph at Walmart - Nov 22nd, 2022 1:30 pm
BioLargo Achieves 111% Growth to a Record $1.5 Million Revenue for Third Quarter 2022 - Nov 15th, 2022 1:30 pm
BioLargo Q3 2022 Earnings Results Webcast and Conference Call on Wednesday, November 16, 2022 - 5 PM Eastern Time - Nov 10th, 2022 3:15 pm
Results from BioLargo's 18-Month Municipal Wastewater Treatment Pilot in Montreal Presented at National Conference - Nov 8th, 2022 1:30 pm
BioLargo Adds Linda Park and Christina Bray to Board of Directors - Nov 3rd, 2022 12:30 pm
BioLargo Sets Another New Quarterly Revenue Record - Oct 26th, 2022 4:15 pm
BioLargo, Inc. Discusses Its PFAS Treatment Solution and Odor Control Technology with The Stock Day Podcast - Oct 25th, 2022 4:57 pm
BioLargo Secures Product Recovery Management (PRM) as Channel Partner and Contract Manufacturer for BioLargo’s Water Treatment Technologies - Oct 6th, 2022 12:30 pm
BioLargo Achieves 185% Growth to $1.3 Million Revenue for Second Quarter 2022, as Published in Quarterly Report - Aug 16th, 2022 12:30 pm
BioLargo Q2 2022 Earnings Results Webcast and Conference Call on Wednesday, August 17, 2022 - 4 PM Eastern Time - Aug 12th, 2022 12:30 pm
BioLargo Secures First PFAS Mitigation Customer and Signs New Channel Partner for PFAS Remediation - Aug 11th, 2022 2:30 pm
BioLargo Sets New Quarterly Revenue Record - Aug 3rd, 2022 12:30 pm
BioLargo Engineering, Science & Technologies Selected to Help Make Novel Nuclear Reactor Fuel Production System - Jun 30th, 2022 12:30 pm
BioLargo to Present at the LD Micro Invitational XII Investor Conference on June 7-9, 2022 - May 31st, 2022 1:36 pm
BioLargo, Inc. Discusses Record-Breaking Quarter on The Stock Day Podcast - May 23rd, 2022 1:00 pm
BioLargo Q1 2022 Earnings Results Webcast and Conference Call on Thursday, May 19, 2022 - 4:00 PM Eastern Time - May 17th, 2022 5:50 pm
BioLargo's First Quarterly Report of 2022 Highlights: Record Company-wide Revenues, Subsidiaries Achieving and Approaching Profitability, and Progress of Key Growth Catalysts - May 17th, 2022 12:30 pm
BioLargo Continues Growth Trend by Breaking Quarterly Revenue Record - Apr 20th, 2022 12:30 pm